SAM #fc2eadda208949a59a22820eaf43b0ad

Sole Source Contract Modification for FDA Compliance by DHA/Army Medical Research Acquisition Activity

This notice announces the Defense Health Agency Contracting Agency's intent to modify an existing sole source contract for the Warfighter Protection and Acute Care Project Management Office. - Sole source contract modification to increase cost ceiling - Supports compliance with FDA Emergency Use Authorization (EUA) and IND application #14047 - Covers additional consultant, professional travel, and regulatory costs - Market research found no other FDA licensed companies for CPP manufacture and licensure in the U.S. - No specific vendors, OEMs, products, or quantities disclosed - Place of performance is Fort Detrick, Frederick, Maryland - Not a request for proposals; informational notice only

Description

The Defense Health Agency Contracting Agency (DHACA), on behalf of the Warfighter Protection and Acute Care Project Management Office (WPAC PMO) of the Operational Medical Solutions (OPMED), is issuing this Notice of Intent to Modify an Existing Contract within Scope. This is not a request for proposals. This notice does not represent a commitment by the government to pay for costs incurred from the preparation and/or submission of data in response to this notice.

View original listing